Vinorelbine Tartrate
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Colon Cancer
Conditions
Colon Cancer
Trial Timeline
Mar 1, 2018 → Mar 17, 2020
NCT ID
NCT03482362About Vinorelbine Tartrate
Vinorelbine Tartrate is a phase 2 stage product being developed by Eli Lilly for Colon Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT03482362. Target conditions include Colon Cancer.
What happened to similar drugs?
4 of 14 similar drugs in Colon Cancer were approved
Approved (4) Terminated (5) Active (6)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03482362 | Phase 2 | Completed |
Competing Products
20 competing products in Colon Cancer